For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Novavax, Inc. (NASDAQ: NVAX) was $16.44 for the day, up 8.73% from the previous closing price of $15.12. In other words, the price has increased by $8.73 from its previous closing price. On the day, 14.82 million shares were traded. NVAX stock price reached its highest trading level at $16.935 during the session, while it also had its lowest trading level at $14.66.
Ratios:
Our analysis of NVAX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.90.
On May 10, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $4 to $12.
B. Riley Securities Upgraded its Neutral to Buy on August 09, 2023, while the target price for the stock was maintained at $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 21 ’24 when YOUNG JAMES F sold 7,500 shares for $14.09 per share. The transaction valued at 105,675 led to the insider holds 61,760 shares of the business.
YOUNG JAMES F sold 7,500 shares of NVAX for $102,881 on Jun 18 ’24. The Director now owns 69,260 shares after completing the transaction at $13.72 per share. On Jun 17 ’24, another insider, Dubovsky Filip, who serves as the President, R&D of the company, sold 13,904 shares for $14.47 each. As a result, the insider received 201,164 and left with 66,613 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVAX now has a Market Capitalization of 2421579264 and an Enterprise Value of 2408702464. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.32. Its current Enterprise Value per Revenue stands at 2.417 whereas that against EBITDA is -7.215.
Stock Price History:
The Beta on a monthly basis for NVAX is 1.98, which has changed by 1.027127 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, NVAX has reached a high of $23.86, while it has fallen to a 52-week low of $3.53. The 50-Day Moving Average of the stock is 23.96%, while the 200-Day Moving Average is calculated to be 126.59%.
Shares Statistics:
NVAX traded an average of 16.36M shares per day over the past three months and 7153830 shares per day over the past ten days. A total of 139.51M shares are outstanding, with a floating share count of 133.33M. Insiders hold about 5.04% of the company’s shares, while institutions hold 48.93% stake in the company. Shares short for NVAX as of 1719532800 were 29527000 with a Short Ratio of 1.80, compared to 1717113600 on 38211138. Therefore, it implies a Short% of Shares Outstanding of 29527000 and a Short% of Float of 25.55.
